Detalhe da pesquisa
1.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 390(14): 1265-1276, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598794
2.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
N Engl J Med
; 389(2): 137-147, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272535
3.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer
; 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38750115
4.
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
Oncologist
; 29(5): e690-e698, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377176
5.
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.
N Engl J Med
; 383(21): 2018-2029, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207094
6.
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.
N Engl J Med
; 383(14): 1328-1339, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997907
7.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(18): 1711-1723, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32955177
8.
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(10): 944-957, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877583
9.
Safety Analysis of Salvage Surgery for Advanced Stages or Metastatic Lung Cancers.
Thorac Cardiovasc Surg
; 70(3): 273-276, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34233366
10.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499874
11.
Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer.
Future Oncol
; 17(34): 4649-4656, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34585621
12.
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.
Future Oncol
; 17(35): 4827-4835, 2021 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34723634
13.
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non-Small Cell Lung Cancer: Results from a Real-World Population.
Oncologist
; 24(11): e1165-e1171, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996007
14.
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells.
Stem Cells
; 36(5): 633-640, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29352734
15.
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
Int J Mol Sci
; 20(16)2019 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416192
16.
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study.
Lancet Oncol
; 19(11): 1468-1479, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262187
17.
Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC.
Br J Cancer
; 118(1): 38-42, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29149104
18.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979383
19.
Stereotactic body radiation therapy for mediastinal lymph node metastases: how do we fly in a 'no-fly zone'?
Acta Oncol
; 57(11): 1532-1539, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280618
20.
Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.
BMC Health Serv Res
; 18(1): 147, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29490654